To read more on this topic click here.
New molecule could reverse neurodegeneration in Parkinson’s
News
Author: Simge Eva DoganPublished: 11 October 2018
Prep: Cook: Serves:
Researchers at a university in Spain have discovered a new molecule which they claim can block and reverse neurodegeneration in Parkinson’s.
The molecule – named SynuClean-D – is able to reduce alpha-synuclein aggregations which cause degeneration.
The study – published in science journal ‘PNAS’ – explains how researchers at the Universitat Autònoma de Barcelona, Spain, tested over 14,000 molecules before discovering SynuClean-D.
They then tested the molecule on a Caenorhabditis worm – one of the most commonly used animals when researching neurodegenerative diseases – finding that it boosted its mobility and protected it from neural degeneration.
Salvador Ventura, the study coordinator, said: “Everything seems to indicate that the molecule we identified, the SynuClean-D, may provide therapeutic applications for the treatment of neurodegenerative diseases such as Parkinson’s in the future.”
For more information on the latest Parkinson’s research please visit Parkinson’s Europe website.
Last Month
Next Month
Share this story
Related articles
Interviews
Young onset Parkinson’s: “How I look is not how I feel”
The first in our series profiling Parkinson's Vision 2020 speakers
READ MOREGlobal update
“We want the feeling of togetherness to take centre stage”
An exciting table tennis event for Parkinson’s disease community
READ MOREsponsored article
Advances
Better results and fewer side effects with personalised DBS Therapy
Ongoing studies: better results in DBS with innovative technology
READ MORE
Comments